Search TDOC
Teladoc Health, Inc.
NYSE · CIK 1477449
Last close5.52
Daily change-0.15 (-2.65%)
10 Years gain-69.04%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
TDOC · STANDARD
SIC 8011 · Services-Offices & Clinics of Doctors of Medicine · Fiscal year end 1231
Fundamental
22.4Momentum
100.0Acceleration
100.0Confidence
78.0Annual Revenue12
Quarterly Revenue39
Annual CFO11
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.9 / 25
Quality18.2 / 25
Capital Efficiency0.0 / 20
Balance Sheet3.3 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 34.4547 percentage points.
Key Metrics
Revenue Growth TTM-3.1%OK
Revenue CAGR 3Y1.68%OK
Gross Marginn/aMISSING
Operating Margin-8.28%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-42.14%OK
Incremental Operating Margin 3Y9,416.15%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y3.95%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $2.53B | n/a | -$262.96M | $294.36M | $285.46M | n/a | -10.39% | 11.28% | -52.1% | 176.22M |
| 2025 FY Dec 31, 2024 | $2.57B | n/a | -$1.02B | $293.68M | $282.89M | n/a | -39.73% | 11.01% | -115.61% | 170.56M |
| 2025 FY Dec 31, 2023 | $2.60B | n/a | -$248.55M | $350.02M | $338.56M | n/a | -9.55% | 13.01% | -15.15% | 164.58M |
| 2024 FY Dec 31, 2022 | $2.41B | n/a | -$13.65B | $189.29M | $172.81M | n/a | -567.27% | 7.18% | n/a | 161.46M |
| 2023 FY Dec 31, 2021 | $2.03B | n/a | -$265.63M | $193.99M | $185.46M | n/a | -13.07% | 9.12% | n/a | 156.94M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $2.48B | sum latest 4 fiscal quarters Revenue | OK | 0001477449-26-000038, 0001477449-25-000120 |
| Revenue Growth TTM | -3.1% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001477449-26-000038, 0001477449-25-000120 |
| Revenue CAGR 3Y | 1.68% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001477449-26-000012 |
| Revenue CAGR 5Y | 18.26% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001477449-26-000012 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001477449-26-000038, 0001477449-25-000120 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Margin | -8.28% | Operating Income / Revenue | OK | 0001477449-26-000038, 0001477449-25-000120 |
| ROIC | -42.14% | NOPAT / Average Invested Capital | OK | 0001477449-26-000038, 0001477449-25-000120 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001477449-26-000038 |
| Current Ratio | 0.83x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $13.69 | Revenue / Diluted Shares | OK | 0001477449-26-000038, 0001477449-25-000120 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0001477449-26-000012 |